Republic Technologies Inc. (CSE:DOCT)
 0.4600
 +0.0100 (2.22%)
  Oct 31, 2025, 1:41 PM EDT
Republic Technologies Statistics
Total Valuation
CSE:DOCT has a market cap or net worth of CAD 15.23 million. The enterprise value is 16.14 million.
| Market Cap | 15.23M | 
| Enterprise Value | 16.14M | 
Important Dates
The next estimated earnings date is Wednesday, November 26, 2025.
| Earnings Date | Nov 26, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
| Current Share Class | 32.49M | 
| Shares Outstanding | n/a | 
| Shares Change (YoY) | +96.25% | 
| Shares Change (QoQ) | +105.64% | 
| Owned by Insiders (%) | 37.79% | 
| Owned by Institutions (%) | n/a | 
| Float | 16.93M | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| PB Ratio | -64.08 | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | -6.69 | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
The company has a current ratio of 0.93
| Current Ratio | 0.93 | 
| Quick Ratio | 0.05 | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | -15.63 | 
Financial Efficiency
| Return on Equity (ROE) | n/a | 
| Return on Assets (ROA) | -28.21% | 
| Return on Invested Capital (ROIC) | -207.74% | 
| Return on Capital Employed (ROCE) | 303.86% | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | n/a | 
| Employee Count | n/a | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
| Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
The stock price has increased by +1,483.33% in the last 52 weeks. The beta is 7,850.97, so CSE:DOCT's price volatility has been higher than the market average.
| Beta (5Y) | 7,850.97 | 
| 52-Week Price Change | +1,483.33% | 
| 50-Day Moving Average | 0.56 | 
| 200-Day Moving Average | 0.39 | 
| Relative Strength Index (RSI) | 46.27 | 
| Average Volume (20 Days) | 40,353 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | 0.21 | 
Income Statement
| Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | -722,294 | 
| Pretax Income | -2.41M | 
| Net Income | -2.41M | 
| EBITDA | n/a | 
| EBIT | -722,294 | 
| Earnings Per Share (EPS) | -0.16 | 
Balance Sheet
The company has 161,835 in cash and 1.05 million in debt, giving a net cash position of -886,484.
| Cash & Cash Equivalents | 161,835 | 
| Total Debt | 1.05M | 
| Net Cash | -886,484 | 
| Net Cash Per Share | n/a | 
| Equity (Book Value) | -237,703 | 
| Book Value Per Share | -0.01 | 
| Working Capital | -237,703 | 
Cash Flow
| Operating Cash Flow | -632,101 | 
| Capital Expenditures | n/a | 
| Free Cash Flow | n/a | 
| FCF Per Share | n/a | 
Margins
| Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
CSE:DOCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -96.25% | 
| Shareholder Yield | -96.25% | 
| Earnings Yield | -15.84% | 
| FCF Yield | n/a | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
The last stock split was on December 30, 2022. It was a reverse split with a ratio of 0.1.
| Last Split Date | Dec 30, 2022 | 
| Split Type | Reverse | 
| Split Ratio | 0.1 | 
Scores
| Altman Z-Score | n/a | 
| Piotroski F-Score | 2 |